Skip to content
Hyper Jackpot Studio

Users Coming Off Anti-Obesity Jabs Put On Pounds at a Quadrupled Rate Compared to Dieters

Image of medical syringe and weighing machine
Weight management often requires ongoing approaches.

New research reveals that people who discontinue blockbuster slimming jabs like Mounjaro or Wegovy tend to recover lost weight far faster than those who stop conventional lifestyle plans.

Research printed in a major health publication shows that while obese people often shed about a fifth of their total mass while undergoing treatment, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.

"Users purchasing these drugs must be informed of the danger of quick weight regain when the therapy ends," cautioned expert Dr. Susan Jebb.

That rate of recovery implies a reversion to pre-treatment weight in about a year and a half.

Analyzing Therapies

The research, which examined dozens of trials involving thousands of participants, compared the results of GLP-1 agonists with other pills.

The team emphasize that people who lose weight through diet and exercise generally experience a less rapid creep back—around 0.1 kg a month—after stopping.

Understanding the Rapid Regain

Experts suggest the way of the drugs explains the heightened regain.

GLP-1 drugs mimic a natural hormone called GLP-1, which controls appetite.

"Sustained high doses of the hormone levels several times higher than normal may cause the system to generate a reduced amount of its own natural GLP-1, and could diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher.

"Stopping of this hormone supplement leads to hunger is unsuppressed, making overeating much more probable."

An Ongoing Issue?

Health authorities suggest the injections for people with obesity-related health risks, accompanied by recommended lifestyle changes.

Many experts contend that, due to the significant potential of weight regain, the therapy should be considered ongoing.

This opinion is echoed by drug manufacturers, who say that the results "emphasize the long-term nature of excess weight," akin to managing diseases like hypertension.

User Experiences

Individuals who have come off the jabs describe a sudden resurgence of hunger.

"I experienced a trigger that goes on and you become ravenous," described a patient.

The struggle is worsened if individuals have not adopted sustainable dietary or behavioural modifications during treatment.

Widespread Interest

Recent estimates indicate that a significant number of adults in the UK have used these injections in the past year, with desire being substantial.

  • Adoption is higher among females than males.
  • The middle-aged demographic shows the greatest usage rates.
  • Many access the medications through private healthcare rather than public health services.

Ultimately, experts caution that while GLP-1 drugs are potent tools for weight loss, they are not a standalone fix and maintained weight loss hinges on combined lifestyle management.

Written by

Carla Friedman

Maya Chen is a game designer and tech writer with over a decade of experience in interactive media and digital storytelling.

Hyper Jackpot Studio

Type to search articles.